These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11157682)
1. Do interventions to reduce coronary heart disease reduce the incidence of type 2 diabetes? A possible role for inflammatory factors. Haffner SM Circulation; 2001 Jan; 103(3):346-7. PubMed ID: 11157682 [No Abstract] [Full Text] [Related]
2. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies. Elam MB; Cushman W; Applegate WB; Heimberg M Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876 [No Abstract] [Full Text] [Related]
3. [Statin treatment in type 2 diabetes. Is it a must today?]. Faust M MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527 [No Abstract] [Full Text] [Related]
4. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS). Lim PO; Yee KM Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109 [No Abstract] [Full Text] [Related]
5. Long-term follow-up of the West of Scotland Coronary Prevention Study. McEvoy JW; Margey R; Blake GJ N Engl J Med; 2008 Jan; 358(2):193; author reply 194-5. PubMed ID: 18184967 [No Abstract] [Full Text] [Related]
6. Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes. Greenfield JR; Chisholm DJ Aust N Z J Med; 2000 Aug; 30(4):483-91. PubMed ID: 10985515 [No Abstract] [Full Text] [Related]
8. Statins for stroke: the second story? Plutzky J; Ridker PM Circulation; 2001 Jan; 103(3):348-50. PubMed ID: 11157683 [No Abstract] [Full Text] [Related]
9. Cholesterol and coronary heart disease: new data from the WOSCOP Study. Poli A Pharmacol Res; 1997 Mar; 35(3):171-2. PubMed ID: 9229403 [No Abstract] [Full Text] [Related]
10. [The effectiveness in type 2 diabetes prevention: a forced landing to reality]. Costa B Med Clin (Barc); 2008 Mar; 130(8):295-7. PubMed ID: 18358121 [No Abstract] [Full Text] [Related]
11. Long-term follow-up of the West of Scotland Coronary Prevention Study. Tsubokura M; Kami M N Engl J Med; 2008 Jan; 358(2):193-4; author reply 194-5. PubMed ID: 18193526 [No Abstract] [Full Text] [Related]
12. Long-term follow-up of the West of Scotland Coronary Prevention Study. DeFilippis AP; Bansal S; Blumenthal RS N Engl J Med; 2008 Jan; 358(2):194; author reply 194-5. PubMed ID: 18193527 [No Abstract] [Full Text] [Related]
14. Updated guidelines support even lower cholesterol levels for at-risk patients. Levenson D Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342 [No Abstract] [Full Text] [Related]
15. The West of Scotland Coronary Prevention Study: a trial of cholesterol reduction in Scottish men. Shepherd J Am J Cardiol; 1995 Sep; 76(9):113C-117C. PubMed ID: 7572679 [TBL] [Abstract][Full Text] [Related]
16. Summaries for patients. Benefits of lowering cholesterol levels in older patients. Ann Intern Med; 2001 May; 134(10):S-4. PubMed ID: 11357858 [No Abstract] [Full Text] [Related]
17. Strategies to reduce complications of type 2 diabetes. Ullom-Minnich P J Fam Pract; 2004 May; 53(5):366-75. PubMed ID: 15125821 [No Abstract] [Full Text] [Related]
19. Statins for all patients with type 2 diabetes: not so soon. Garg A Lancet; 2004 Aug 21-27; 364(9435):641-2. PubMed ID: 15325810 [No Abstract] [Full Text] [Related]
20. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640 [No Abstract] [Full Text] [Related] [Next] [New Search]